Patent details

EP4130273 Title: PRODUCTION OF HETEROLOGOUS POLYPEPTIDES IN MICROALGAE, MICROALGAL EXTRACELLULAR BODIES, COMPOSITIONS, AND METHODS OF MAKING AND USES THEREOF

Basic Information

Publication number:
EP4130273
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Unitary Effect Registered
Application number:
EP221817042
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PRODUCTION OF HETEROLOGOUS POLYPEPTIDES IN MICROALGAE, MICROALGAL EXTRACELLULAR BODIES, COMPOSITIONS, AND METHODS OF MAKING AND USES THEREOF
French Title of Invention:
PRODUCTION DE POLYPEPTIDES HÉTÉROLOGUES DANS DES MICRO-ALGUES, CORPS EXTRACELLULAIRE DE MICRO-ALGUES, COMPOSITIONS ET PROCÉDÉS DE FABRICATION ET LEURS UTILISATIONS
German Title of Invention:
HERSTELLUNG HETEROLOGER POLYPEPTIDE IN MIKROALGEN, EXTRAZELLULÄRE ALGENKÖRPER, ZUSAMMENSETZUNGEN UND VERFAHREN ZUR HERSTELLUNG SOWIE VERWENDUNGEN DAVON
SPC Number:

Unitary Effect

Unitary Effect Requested:
Yes
Unitary Effect Request Filing Date:
12/07/2024
Link to UPP Register:
European Patent Register
Unitary Effect Request Withdrawal Date:
Unitary Effect Status:
Unitary Effect Registered
Unitary Effect Acceptance Decision Date:
19/07/2024
Unitary Effect Rejection Decision Date:
Unitary Effect Date:
12/06/2024
Unitary Effect Registration Date:
19/07/2024
Unitary Effect Re-establishment of rights Filing Date:
Unitary Effect Re-establishment of rights EPO Decision :
Unitary Effect Re-establishment of rights EPO Decision Date:
Explanatory Text UE:
Safety Net Request Date:
Safety Net Decision Date:
Safety Net Decision Outcome:
SPC Number:

Dates

Filing date:
28/12/2010
Grant date:
12/06/2024
EP Publication Date:
08/02/2023
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
12/06/2024
EP B1 Publication Date:
12/06/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
28/12/2030
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
08/08/2024
 
 

Name:
Sanofi
Address:
46 avenue de la Grande Armée, 75017 Paris, France (FR)

History of Owners

From:
05/06/2024
To:
08/08/2024

Name:
Sanofi Vaccine Technologies, S.A.S.
Address:
102 Avenue Gaston Roussel, 93230 Paris, France (FR)

Inventor

1

Name:
ZIRKLE, Ross Eric
Address:
United States (US)

2

Name:
LIPPMEIER, James Casey
Address:
United States (US)

3

Name:
BAYNE, Anne-Cecile V.
Address:
United States (US)

4

Name:
APT, Kirk Emil
Address:
United States (US)

Priority

1

Priority Number:
29044109 P
Priority Date:
28/12/2009
Priority Country:
United States (US)

2

Priority Number:
29046909 P
Priority Date:
28/12/2009
Priority Country:
United States (US)

3

Priority Number:
41335310 P
Priority Date:
12/11/2010
Priority Country:
United States (US)

Classification

IPC classification:
C12N 15/44; A61P 31/12; A61P 31/16; A61P 37/04; C12N 1/12; C12P 21/02;

Publication

European Patent Bulletin

1

Issue number:
202424
Publication date:
12/06/2024
Description:
Grant (B1)

2

Issue number:
202437
Publication date:
11/09/2024
Description:
Transfer of Rights

3

Issue number:
202434
Publication date:
21/08/2024
Description:
Unitary Effect Request Receipt

4

Issue number:
202434
Publication date:
21/08/2024
Description:
Unitary Effect Request Acceptance

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages